Cellmabs is focused on researching and developing innovative biopharmaceuticals for the treatment of cancer. The team is comprised of renowned scientists and international experts in the field of glycoimmunology and oncology.
Biotechnology, glycoimmunology, oncology
Between €2.5 million-5 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as CellmAbs? We’re happy to assist you with our Startup Sourcing service.